For Pharma & Health Product Partners

Reach people actively navigating cancer care

Cancer Copilot offers pharmaceutical and health-product organizations a way to present relevant product information within a focused cancer-support and resource experience.

Advertising is subject to review, applicable law, industry standards, and clear sponsorship labeling.
Strategic Context

Put useful information in the right context

01

Relevant audiences

Reach people actively organizing oncology treatment and support.

02

Clear presentation

Share useful product information in a calm, easy-to-evaluate format.

03

Transparent sponsorship

Sponsored content is clearly identified and kept distinct from care-plan guidance.

Partnership Options

Potential advertising opportunities

Sponsored product listings

Present relevant products in clearly labeled resource directories.

Enhanced information pages

Give audiences a structured place to review product details and supporting information.

Educational sponsorships

Support useful educational content with transparent brand attribution.

Campaign placements

Plan focused placements around appropriate audiences, timing, and context.

How It Works

A responsible review process

01

Submit request

02

Provide details

03

Review compliance

04

Confirm transparency

05

Begin placement

Trust & Safety

Principles for trusted promotion

Clear labeling

People should always know when content is sponsored.

Care-plan separation

Promotional content stays distinct from clinical instructions.

Fair balance

Relevant limitations and safety information remain visible.

Display priority

Placement should support usefulness, not interruption.

Safety expectations

Claims must be accurate, appropriate, and reviewable.

Active compliance

Partnerships remain subject to ongoing review.

Get in touch

Start a conversation

Tell us about the product, program, or educational initiative you would like to present to the Cancer Copilot audience.

Quick Inquiry Form

Bring relevant product information to a focused cancer-support audience